HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.

AbstractBACKGROUND:
Insulin-like growth factor (IGF)-I signalling stimulates proliferation, survival, and invasion in malignant mesothelioma and other tumour types. Studies have found that tumourigenesis is linked to dysregulation of cap-dependent protein translation.
METHODS:
The effect of IGF stimulation on cap-mediated translation activation in mesothelioma cell lines was studied using binding assays to a synthetic 7-methyl GTP-cap analogue. In addition, cap-mediated translation was genetically repressed in these cells with a dominant active motive of 4E-BP1.
RESULTS:
In most mesothelioma cell lines, IGF-I stimulation resulted in a hyperphosphorylation-mediated inactivation of 4E-BP1 compared with that in normal mesothelial cells. An inhibitor of Akt diminished IGF-I-mediated phosphorylation of 4E-BP1, whereas inhibiting MAPK signalling had no such effect. IGF-I stimulation resulted in the activation of the cap-mediated translation complex as indicated by an increased eIF4G/eIF4E ratio in cap-affinity assays. Akt inhibition reversed the eIF4G/eIF4E ratio. Mesothelioma cells transfected with an activated 4E-BP1 protein (4E-BP1(A37/A46)) were resistant to IGF-I-mediated growth, motility, and colony formation. In a murine xenograft model, mesothelioma cells expressing the dominant active 4E-BP1(A37/A46) repressor protein showed abrogated tumourigenicity compared with control tumours.
CONCLUSION:
IGF-I signalling in mesothelioma cells drives cell proliferation, motility, and tumourigenesis through its ability to activate cap-mediated protein translation complex through PI3K/Akt/mTOR signalling.
AuthorsB A Jacobson, A De, M G Kratzke, M R Patel, J Jay-Dixon, B A Whitson, A A Sadiq, P B Bitterman, V A Polunovsky, R A Kratzke
JournalBritish journal of cancer (Br J Cancer) Vol. 101 Issue 3 Pg. 424-31 (Aug 04 2009) ISSN: 1532-1827 [Electronic] England
PMID19603014 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Cell Cycle Proteins
  • Chromones
  • EIF4EBP1 protein, human
  • Eif4ebp1 protein, mouse
  • Eukaryotic Initiation Factor-4F
  • Eukaryotic Initiation Factors
  • Morpholines
  • Phosphoproteins
  • RNA Cap-Binding Proteins
  • RNA Caps
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1
  • Proto-Oncogene Proteins c-akt
Topics
  • Adaptor Proteins, Signal Transducing (physiology)
  • Animals
  • Carrier Proteins (physiology)
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Chromones (pharmacology)
  • Eukaryotic Initiation Factor-4F (physiology)
  • Eukaryotic Initiation Factors
  • Humans
  • Insulin-Like Growth Factor I (physiology)
  • Mesothelioma (etiology, therapy)
  • Mice
  • Morpholines (pharmacology)
  • Neoplasm Transplantation
  • Phosphatidylinositol 3-Kinases (physiology)
  • Phosphoproteins (physiology)
  • Protein Biosynthesis
  • Proto-Oncogene Proteins c-akt (physiology)
  • RNA Cap-Binding Proteins
  • RNA Caps (physiology)
  • Receptor, IGF Type 1 (physiology)
  • Signal Transduction
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: